The Rheumatology Research Foundation hosted the 10th Annual Investigators’ Meeting in St. Louis, June 24–25. The meeting provides Foundation-funded investigators an opportunity to learn about recent findings and research projects, network, exchange ideas and collaborate on future projects. More than 30 rheumatology professionals were in attendance, with presentations from 21 investigators. James O’Dell, MD, professor…
The Rheumatology Research Foundation hosted the 9th annual Investigators’ Meeting in Atlanta on June 24–25. As a requirement for Foundation innovative research and pilot grant recipients, Foundation-funded investigators meet annually to provide updates and status reports on the work they are doing to advance treatments and cures for rheumatic diseases. More than 50 attendees enjoyed…
Despite new therapeutics, progress for RA patients has virtually stalled over the past 10 years. In this article, the authors discuss many options to advance to a cure and the evidence for them, including the combination of low-dose methotrexate and anti-TNF; targeting angiogenesis and tissue damage pathways directly; antigen-specific therapy; potential combination of TNF and IL17 blockade; and targeting inhibitory receptors and regulatory T cells.
Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies